Moderna, Inc. - Common Stock (MRNA)

The vaccine maker is making an increasingly robust case that it isn't just a pandemic stock.

The stocks featured in this article are seeing some big returns. Over the past month, they’ve outpaced the market due to some combination of positive news, u...

Both have attracted considerable attention from Wall Street recently.

What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 2.9% in the afternoon session after Rothschild & Co Redburn analyst Simon Baker dow...

A solid moat favors revenue growth, and that's good news for investors.

The company is coming back into the spotlight thanks to recent developments.

Shares of Moderna Inc (NASDAQ: MRNA) are trading lower Wednesday morning, taking a breather following a 170% surge over the trailing month.

Moderna Inc (NASDAQ: MRNA) shares are trading higher Tuesday morning. Here's what investors need to know.

The company may be on track to its next product.

Moderna could be on the verge of a breakthrough, but the biotech's MRNA cancer vaccine catalyst is overly priced in.

These ETFs both hold S&P 500 members but with very different allocations.

Wrapping up Q2 earnings, we look at the numbers and key takeaways for the therapeutics stocks, including Moderna (NASDAQ:MRNA) and its peers. Over the next f...